Rezolute, Inc. (RZLT)
2.49
+0.02
(+0.81%)
USD |
NASDAQ |
Mar 20, 16:00
2.48
-0.01
(-0.40%)
After-Hours: 20:00
Rezolute Research and Development Expense (Quarterly) : 14.35M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| XOMA Royalty Corp. | 0.281M |
| Silvergate Capital Corp. | -- |
| ACADIA Pharmaceuticals, Inc. | 84.76M |
| Alnylam Pharmaceuticals, Inc. | 372.22M |
| Savara, Inc. | 20.90M |